EDX Medical confirms date for 2025 Annual General Meeting

EDX Medical Group Plc (AQSE: EDX), which develops innovative digital diagnostic products and services supporting personalised treatments for cancer, heart disease and infectious diseases, has announced that its annual general meeting (AGM) will be held at the Marcus Beck Library, 3rd Floor, Royal School of Medicine, 1 Wimpole Street, Westminster, London, W1G 0AE on 29 September 2025 at 2:00 p.m.

The annual report and financial statements for the year ended 31 March 2025, Notice of AGM and Form of Proxy will be posted today, 1 September 2025, to eligible shareholders. Electronic copies will be shortly available on the Company’s website at: https://edxmedical.co.uk/documents/

Share on:

You might also enjoy reading EDX Medical Group to launch highly accurate early detection test for testicular cancer

Written by: Amilia Stone

Find more news, interviews, share price & company profile here for:
EDX Medical Group Plc

Latest Company News

EDX Medical confirms date for 2025 Annual General Meeting

EDX Medical will hold its AGM on 29 September 2025 at 2:00 p.m. at the Marcus Beck Library, Royal School of Medicine, London. The meeting will cover standard business matters and provide shareholders with an update on company progress.

EDX Medical reports 2025 results and advances in cancer diagnostics

EDX Medical Group has published its Annual Report for the year ending 31 March 2025, highlighting the development of a new AI-driven prostate cancer test, a £3 million fundraising, expanded European partnerships, and a service agreement with Royal Marsden NHS Foundation Trust.

EDX Medical Group to complete the development of new pneumonia test

EDX Medical will partner with the Intensive Care Unit at Cambridge University Hospitals NHS Foundation Trust to support the further advancement of a highly precise test that identifies the DNA or RNA of the microbes that cause lung infection in critically ill patients.